{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:04:18Z","timestamp":1762855458844,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jogoh.2021.102289","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T02:17:37Z","timestamp":1639189057000},"page":"102289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Added value of anti-M\u00fcllerian hormone serum concentration in assisted reproduction clinical practice using highly purified human menopausal gonadotropin (HP-hMG)"],"prefix":"10.1016","volume":"51","author":[{"given":"Paul","family":"Barri\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9raldine","family":"Porcu-Buisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Avril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Hamamah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jogoh.2021.102289_bib0001","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"2","key":"10.1016\/j.jogoh.2021.102289_bib0002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"8","key":"10.1016\/j.jogoh.2021.102289_bib0003","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/humrep\/deu090","article-title":"Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol","volume":"29","author":"Broekmans","year":"2014","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102289_bib0004","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/138920112799361972","article-title":"Possibilities and limits of ovarian reserve testing in ART","volume":"13","author":"La Marca","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"issue":"12","key":"10.1016\/j.jogoh.2021.102289_bib0005","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1210\/jc.2010-0701","article-title":"Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology","volume":"95","author":"Ledger","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jogoh.2021.102289_bib0006","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/dep210","article-title":"Table ESIGfRE\u2013AR. Anti-Mullerian hormone (AMH): what do we still need to know?","volume":"24","author":"La Marca","year":"2009","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.jogoh.2021.102289_bib0007","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.jogoh.2021.102289_bib0008","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil Steril"},{"journal-title":"Agence de la biom\u00e9decine","article-title":"Evaluation des r\u00e9sultats des centres d'assistance m\u00e9dicale \u00e0 la proc\u00e9ation pratiquant la f\u00e9condation in vitro en France","year":"2016","key":"10.1016\/j.jogoh.2021.102289_bib0009"},{"issue":"1","key":"10.1016\/j.jogoh.2021.102289_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40258-017-0361-7","article-title":"Cost-effectiveness analysis of the gonadotropin treatments HP-hMG and rFSH for assisted reproductive technology in france: a markov model analysis","volume":"16","author":"Barriere","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"issue":"5","key":"10.1016\/j.jogoh.2021.102289_bib0011","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S1472-6483(10)61098-X","article-title":"Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial","volume":"8","author":"Aboulghar","year":"2004","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"10.1016\/j.jogoh.2021.102289_bib0012","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0015-0282(00)00471-4","article-title":"A comparative study of high fixed-dose and decremental-dose regimens of gonadotropins in a minidose gonadotropin-releasing hormone agonist flare protocol for poor responders","volume":"73","author":"Cedrin-Durnerin","year":"2000","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.jogoh.2021.102289_bib0013","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1472-6483(10)60654-2","article-title":"Impact of duration and dose of gonadotrophins on IVF outcomes","volume":"13","author":"Martin","year":"2006","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102289_bib0014","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/oxfordjournals.humrep.a138053","article-title":"Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study","volume":"8","author":"van Hooff","year":"1993","journal-title":"Human reproduction"},{"issue":"1","key":"10.1016\/j.jogoh.2021.102289_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fertnstert.2004.06.049","article-title":"Blastocyst culture after repeated failure of cleavage-stage embryo transfers: a comparison of day 5 and day 6 transfers","volume":"83","author":"Barrenetxea","year":"2005","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.jogoh.2021.102289_bib0016","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1472-6483(10)60199-X","article-title":"Influence of atmospheric versus reduced oxygen concentration on development of human blastocysts in vitro: a prospective study on sibling oocytes","volume":"17","author":"Kovacic","year":"2008","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102289_bib0017","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.gyobfe.2016.01.005","article-title":"Embryo development in two single-step media: analysis of 2059 sibling oocytes","volume":"44","author":"Durand","year":"2016","journal-title":"Gynecol Obstet Fertil"},{"issue":"10","key":"10.1016\/j.jogoh.2021.102289_bib0018","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10815-017-0997-0","article-title":"Blastocyst utilization rates after continuous culture in two commercial single-step media: a prospective randomized study with sibling oocytes","volume":"34","author":"Sfontouris","year":"2017","journal-title":"J Assist Reprod Genet"},{"issue":"2","key":"10.1016\/j.jogoh.2021.102289_bib0019","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/humrep\/dey370","article-title":"Influence of ultra-low oxygen (2%) tension on in-vitro human embryo development","volume":"34","author":"De Munck","year":"2019","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.jogoh.2021.102289_bib0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.rbmo.2017.01.012","article-title":"A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF\/ICSI cycles","volume":"34","author":"Allegra","year":"2017","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102289_bib0021","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00404-015-3901-0","article-title":"The influence of AMH on IVF success","volume":"293","author":"Gomez","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102289_bib0022","first-page":"215","article-title":"Are age and anti-Mullerian hormone good predictors of ovarian reserve and response in women undergoing IVF?","volume":"22","author":"Scheffer","year":"2018","journal-title":"JBRA Assist Reprod"},{"issue":"4","key":"10.1016\/j.jogoh.2021.102289_bib0023","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/humrep\/dez006","article-title":"Patients\u2019 attitudes and preferences towards a freeze-all strategy in ART treatment","volume":"34","author":"Stormlund","year":"2019","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.jogoh.2021.102289_bib0024","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rbmo.2013.10.018","article-title":"Medical factors associated with early IVF discontinuation","volume":"28","author":"Troude","year":"2014","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.jogoh.2021.102289_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/humupd\/dmy033","article-title":"Fresh versus elective frozen embryo transfer in IVF\/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes","volume":"25","author":"Roque","year":"2019","journal-title":"Hum. Reprod. Update"},{"issue":"25","key":"10.1016\/j.jogoh.2021.102289_bib0026","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJM200006223422511","article-title":"Randomized trials or observational tribulations?","volume":"342","author":"Pocock","year":"2000","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.jogoh.2021.102289_bib0027","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJM200006223422506","article-title":"A comparison of observational studies and randomized, controlled trials","volume":"342","author":"Benson","year":"2000","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.jogoh.2021.102289_bib0028","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","article-title":"Randomized, controlled trials, observational studies, and the hierarchy of research designs","volume":"342","author":"Concato","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2021.102289_bib0029","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fendo.2018.00686","article-title":"Anti-Mullerian hormone during natural cycle presents significant intra and intercycle variations when measured with fully automated assay","volume":"9","author":"Melado","year":"2018","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784721002257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784721002257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:01:29Z","timestamp":1762855289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784721002257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2468784721002257"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2021.102289","relation":{},"ISSN":["2468-7847"],"issn-type":[{"type":"print","value":"2468-7847"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Added value of anti-M\u00fcllerian hormone serum concentration in assisted reproduction clinical practice using highly purified human menopausal gonadotropin (HP-hMG)","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2021.102289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102289"}}